Deoxyribozymes as Inhibitors of Vascular Smooth Muscle Cell Growth
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
337-339
Author(s):
Levon M. Khachigian
Oncogene Suppression by Small Interfering RNAs
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
349-354
Author(s):
Olaf Heidenreich
Therapeutic Potential of Hammerhead Ribozymes in the Treatment of Hyper-Proliferative Diseases
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
369-386
Author(s):
G. Grassi, P. Dawson, G. Guarnieri, R. Kandolf and M. Grassi
The Therapeutic Potential of Hepatocyte Growth Factor for Myocardial Infarction and Heart Failure
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2525-2533
Author(s):
Hongkui Jin, J. Michael Wyss, Renhui Yang and Ralph Schwall
Preface [HotTopic: Novel Therapeutic Perspectives: The Targeted Inhibition of Genes and Proteins (Executive Editor: Felix Hoppe-Seyler)]
Journal:
Current Molecular Medicine
Volume:
4
Page:
ii-ii
Author(s):
Felix Hoppe-Seyler
Antisense Strategies
Journal:
Current Molecular Medicine
Volume:
4
Page:
465-487
Author(s):
Stanley T. Crooke
Ribozymes in the Age of Molecular Therapeutics
Journal:
Current Molecular Medicine
Volume:
4
Page:
489-506
Author(s):
Sepideh Bagheri and Mohammed Kashani-Sabet
Silencing of Disease-related Genes by Small Interfering RNAs
Journal:
Current Molecular Medicine
Volume:
4
Page:
507-517
Author(s):
U. Fuchs, C. Damm-Welk and A. Borkhardt
Peptide Aptamers: Specific Inhibitors of Protein Function
Journal:
Current Molecular Medicine
Volume:
4
Page:
529-538
Author(s):
Felix Hoppe-Seyler, Irena Crnkovic-Mertens, Evangelia Tomai and Karin Butz
Therapeutic Antibodies
Journal:
Current Molecular Medicine
Volume:
4
Page:
539-547
Author(s):
Bernd Groner, Cord Hartmann and Winfried Wels